Award
National Cancer Institute 5P01CA206978-10
Pathology
Recipient
National Cancer Institute (NCI)
Award Amount
$116,547.00
Ceiling
$116,547.00
Awarded
September 08, 2025
Identifier
5P01CA206978-10
Award for pathology research focusing on RS tumor samples and models, funded by the National Cancer Institute, with a total award amount of $116,547.
Description
The project aims to characterize and bank tumor samples from RS patients and engineered RS mouse models. The core will provide resources for human and mouse RS pathology, generate patient-derived RS-PDX primagraft models, and support research on RS tissues. The project includes ex vivo expansion of RS samples, in vivo RS primagraft models, histopathological analysis, tissue microarrays, and immunohistochemistry. Funding is provided by the National Cancer Institute under grant PAR-20-077. The project duration is from September 1, 2016, to August 31, 2026.